Vital Farms, Inc.
No SEC Form 4 filings for $VITL in the last 30 days.
See all $VITL insider activity →Mission Produce (AVO) reported $450M revenue, up 25.8% YoY, beating estimates. Cal-Maine (CALM) saw $539.6M revenue, down 41.5% YoY, missing estimates. Freshpet (FRPT) reported $305.6M revenue, up 15.5% YoY, beating estimates. Vital Farms (VITL) reported $166M revenue, down 10.1% YoY, slightly beating estimates. Stock prices moved accordingly post-earnings.
Stifel reduced its price target for Vital Farms (VITL) to $9 from $11, citing margin concerns and low visibility into recovery. The stock is down 72% year-to-date. Other analysts have mixed views, with some raising targets and others maintaining cautious ratings. Vital Farms reported Q2 revenue of $166M, beating estimates, but EBITDA was negative $27M, missing expectations.
Vital Farms (VITL) shares fell 4.8% to $8.89 after TD Cowen cut its price target to $8, citing cautious outlook. The decline coincided with broader market sell-off due to inflation data. The stock has lost 70.2% YTD and trades 78.8% below its 52-week high. Vital Farms is also exploring strategic alternatives, including a potential take-private deal.
Over the past 7 days, AlphAI's AI scored 4 news stories mentioning VITL (Vital Farms, Inc.). Coverage has skewed bearish: 0 bullish, 1 neutral, and 3 bearish.
Recent VITL coverage spans financial news, market movers and earnings.
Despite guidance strength, the EBITDA miss appears to dominate sentiment for VITL.
The target cut suggests downside pressure as analysts doubt near‑term profitability.
The price‑target cut signals reduced expectations for earnings and valuation, likely pressuring the stock further.
Recap of prior quarter; no new market impact.
Analyst maintains target despite pricing pressure, suggesting limited upside.
AlphAI scores every news story that mentions VITL with an AI model for sentiment and relevance, and aggregates insider trades from Vital Farms, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Mission Produce (AVO) reported $450M revenue, up 25.8% YoY, beating estimates. Cal-Maine (CALM) saw $539.6M revenue, down 41.5% YoY, missing estimates. Freshpet (FRPT) reported $305.6M revenue, up 15.5% YoY, beating estimates. Vital Farms (VITL) reported $166M revenue, down 10.1% YoY, slightly beating estimates. Stock prices moved accordingly post-earnings.
7 min readStifel reduced its price target for Vital Farms (VITL) to $9 from $11, citing margin concerns and low visibility into recovery. The stock is down 72% year-to-date. Other analysts have mixed views, with some raising targets and others maintaining cautious ratings. Vital Farms reported Q2 revenue of $166M, beating estimates, but EBITDA was negative $27M, missing expectations.
2 min readVital Farms (VITL) shares fell 4.8% to $8.89 after TD Cowen cut its price target to $8, citing cautious outlook. The decline coincided with broader market sell-off due to inflation data. The stock has lost 70.2% YTD and trades 78.8% below its 52-week high. Vital Farms is also exploring strategic alternatives, including a potential take-private deal.
2 min readMission Produce beat analyst estimates but its stock fell 5.6%. Cal-Maine reported a 41.5% revenue decline and missed estimates, dropping 7.6%. Del Monte Corporation's revenue grew 3.1% but missed expectations, rising 4.7%. Vital Farms' revenue fell 10.1% but topped estimates, yet its stock dropped 23.7%.
2 min readJefferies maintained a $15 price target on Vital Farms (VITL), citing pressure from easing egg prices and rebuilding layer flocks. USDA forecasts a 2026 egg price of $1.07/dozen, with spot prices at 65 cents. Vital Farms' volumes fell 6% YoY, but demand for pasture-raised eggs remains strong, growing 17% YoY.
1 min readVital Farms (VITL) shares fell 8.8% to $10.26 after Axios reported the company is considering strategic alternatives, including a take-private deal. The market value has dropped over 80% from its peak. Analysts have differing views on the stock's potential, with one setting a $18 price target. The stock is down 65.8% year-to-date and 77.2% from its 52-week high.
2 min readVital Farms (VITL) stock rose 7.5% pre-market after reports it is exploring strategic options, including a potential sale, with a valuation range of $15–$25 per share. StoneX reiterated a Buy rating and $18 target. The S&P 500, Dow Jones, and NASDAQ also gained 1.3%–1.7%, supporting the rally.
2 min readVital Farms (VITL) stock rose 5.4% to $11.15, extending a recovery from multi-year lows. Recent developments include Q2 revenue slightly above estimates, reaffirmed full-year guidance, analyst upgrades, and inclusion in Russell value indices. The stock remains volatile and below its 52-week high of $53.13.
1 min readVital Infrastructure Property Trust (TSX: VITL.UN) reported Q2 2026 results for the three and six months ended June 30, 2026. Net income fell to $0.3 million from $32.6 million a year earlier, while AFFO rose to $0.11 per unit. The REIT generated about $145 million net cash from selling its European portfolio and, after quarter end, bought a Brooklyn health hub for US$89.9 million and agreed to buy a Canadian outpatient facility for about $26.2 million.
6 min readVital Farms (NASDAQ: VITL) shares rose about 3.9% after the company reported Q2 results. Revenue fell 10.1% year over year to $166 million, and the company swung to a net loss of $0.72 per share versus a $0.36 profit a year earlier. Gross margin dropped to 6.6% from 38.9%. Vital Farms reaffirmed full-year revenue guidance.
4 min read
